Table 1:
FDA-approval process for bone grafts, describes 510K, IDE/PMA, and HCTP approval processes.
FDA-approval Processes: | Process of Approval: |
---|---|
510K | The 510K process is a premarket submission is that the device is at least as safe and effective, that is, substantially equivalent, to a legally marketed device [15]. |
IDE/PMA | An IDE allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data. This data will then be used to support the Premarket Approval [16]. |
HCT/P | HCT/P’s are regulated by the Center for Devices and Radiological Health as medical devices and/or are regulated by the Center for Biologics Evaluation and Research [17]. Whether products are regulated by one or both of these agencies depends on the product wanting to be marketed. No premarket approval is needed through the FDA. |
RMAT | RMAT’s must be made with an existing or new Investigational New Drug (IND) application. This designation includes certain human gene therapies and xenogeneic cell products[18]. |